Cognitive outcome measures

Alzheimer Disease and Associated Disorders

Volumn 13, Issue SUPPL. 3, 1999, Pages

  Ferris, Steven H ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Alzheimer disease; Cognitive assessment; Vascular dementia

Indexed keywords

ALZHEIMER DISEASE; COGNITION; COGNITIVE DEFECT; DRUG EFFECT; HUMAN; MULTIINFARCT DEMENTIA; OUTCOME ASSESSMENT; PSYCHOLOGICAL ASPECT; PSYCHOLOGICAL RATING SCALE; REVIEW;

ALZHEIMER DISEASE; COGNITION; COGNITION DISORDERS; DEMENTIA, VASCULAR; HUMANS; OUTCOME ASSESSMENT (HEALTH CARE); PSYCHIATRIC STATUS RATING SCALES;

EID: 0033202768     PISSN: 08930341     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002093-199912003-00020     Document Type: Article

References (9)

1. Committee for Proprietary Medicinal Products (CPMP). Note for guidance on medicinal products in the treatment of Alzheimer's disease. London: European Agency for the Evaluation of Medicinal Products, Human Medicines Evaluation Unit, 1997.
2. Desmond DW, Erkinjuntti T, Sano M, et al. The cognitive syndrome of vascular dementia: implications for clinical trials. Alzheimer Dis Assoc Disord 1999;13(suppl 3):S21-9.
3. Ferris SH, Lucca U, Mohs R, et al. Objective psychometric tests in clinical trials of dementia drugs. Alzheimer Dis Assoc Disord 1997a;3:34-8.
4. Ferris SH, Mackell JA, Mohs R, et al. A multicenter evaluation of new treatment efficacy instruments for Alzheimers disease clinical trials: overview and general results. Alzheimer Dis Assoc Disord 1997b; 11(suppl 2):S1-S12.
5. Leber P. Guidelines for the clinical evaluation of antidementia drugs, first draft. Rockville, MD: US Food and Drug Administration, 1990.
6. Mohs RC, Cohen L. Alzheimer's disease assessment scale (ADAS). Psychopharmacol Bull 1988;24:621-8.
7. Mohs RC, Ferris SH. Measuring response to treatment in Alzheimer's disease: what constitutes meaningful change? Int J Geriatr Psychopharmacol 1998;1:S7-S14.
8. Mohs R, Knopman D, Peterson R, et al. Development of cognitive instruments for use in clinical trials of antidementia drugs: additions to the Alzheimer's disease assessment scale (ADAS) that broaden its scope. Alzheimer Dis Assoc Disord 1997;11 (suppl 2):S13-S21.
9. Rosen WG, Mohs RC, Davis KL. A new rating scale for Alzheimer's disease. Am J Psychiatry 1984;141:1356-64.